185 related articles for article (PubMed ID: 32975893)
1. Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition.
Qama A; Allard N; Cowie B; Davis JS; Davies J
Intern Med J; 2021 Jun; 51(6):910-922. PubMed ID: 32975893
[TBL] [Abstract][Full Text] [Related]
2. Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population.
Davies J; Li SQ; Tong SY; Baird RW; Beaman M; Higgins G; Cowie BC; Condon JR; Davis JS
PLoS One; 2017; 12(9):e0184082. PubMed ID: 28886050
[TBL] [Abstract][Full Text] [Related]
3. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
Cheah BC; Davies J; Singh GR; Wood N; Jackson K; Littlejohn M; Davison B; McIntyre P; Locarnini S; Davis JS; Tong SYC
Vaccine; 2018 Jun; 36(24):3533-3540. PubMed ID: 29735323
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B prevalence in women giving birth in the Northern Territory, Australia, 2005-2015.
Dyda A; McGregor S; Binks P; Davies J; Tong SY; Krause V; Markey P; Qin Li SL; Davis JS; Kaldor JM; Liu B
Commun Dis Intell (2018); 2022 Sep; 46():. PubMed ID: 36154656
[TBL] [Abstract][Full Text] [Related]
5. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.
Hanna JN; Faoagali JL; Buda PJ; Sheridan JW
J Paediatr Child Health; 1997 Feb; 33(1):67-70. PubMed ID: 9069048
[TBL] [Abstract][Full Text] [Related]
6. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
7. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
8. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus and human T-cell lymphotropic virus type 1 co-infection in the Northern Territory, Australia.
Marr I; Davies J; Baird RW
Int J Infect Dis; 2017 May; 58():90-95. PubMed ID: 28315754
[TBL] [Abstract][Full Text] [Related]
10. Status of hepatitis B infection - a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity.
Bhattacharya H; Bhattacharya D; Ghosal SR; Roy S; Sugunan AP
Indian J Med Res; 2015 May; 141(5):653-61. PubMed ID: 26139785
[TBL] [Abstract][Full Text] [Related]
11. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
12. Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan.
Chen CL; Yang JY; Lin SF; Sun CA; Bai CH; You SL; Chen CJ; Kao JH; Chen PJ; Chen DS
J Hepatol; 2015 Aug; 63(2):354-63. PubMed ID: 25795588
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus markers in children and staff in Northern Territory schools.
Gardner ID; Wan X; Simms PA; Worswick DA; Burrell CJ; Mathews JD
Med J Aust; 1992 May; 156(9):638-41. PubMed ID: 1625617
[TBL] [Abstract][Full Text] [Related]
14. Measuring quality of hepatitis B care in a remote Australian Aboriginal community: opportunities for improvement.
Narayana S; Nugent M; Woodman R; Larkin M; Ramachandran J; Muller K; Wigg A
Intern Med J; 2022 Aug; 52(8):1347-1353. PubMed ID: 33979037
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
[TBL] [Abstract][Full Text] [Related]
17. A "one stop liver shop" approach improves the cascade-of-care for Aboriginal and Torres Strait Islander Australians living with chronic hepatitis B in the Northern Territory of Australia: results of a novel care delivery model.
Hla TK; Bukulatjpi SM; Binks P; Gurruwiwi GG; Dhurrkay RG; Davies J
Int J Equity Health; 2020 May; 19(1):64. PubMed ID: 32381081
[TBL] [Abstract][Full Text] [Related]
18. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis.
Graham S; Guy RJ; Cowie B; Wand HC; Donovan B; Akre SP; Ward JS
BMC Infect Dis; 2013 Aug; 13():403. PubMed ID: 24004727
[TBL] [Abstract][Full Text] [Related]
20. Minimization of hepatitis B infection by a 25-year universal vaccination program.
Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
